γ-linolenic acid therapy of human gliomas

Nutrition

Volumn 19, Issue 4, 2003, Pages 305-309

  Bakshi, Ajay ^b   Mukherjee, Debabrata ^b   Bakshi, Asha ^b   Banerji, Ajit K ^b   Das, Undurti N ^a  

^a EFA Sciences LLC   (United States)

^b NONE

Author keywords

linolenic acid; Computed tomography; Glioma; Injection; Intratumoral; Ommaya reservoir

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; GAMMA LINOLENIC ACID; GLUCOCORTICOID; LOMUSTINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SAFETY; FEMALE; GLIOMA; HUMAN; INTRACRANIAL PRESSURE; LIFESPAN; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ALPHA-LINOLENIC ACID; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; INJECTIONS, INTRALESIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0037382454     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(02)00862-6     Document Type: Article

References (41)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics (1999). CA Cancer J Clin. 49:1999;8.
2. DeAngelis L.M. Brain tumors. N Engl J Med. 344:2001;114.
3. Radhakrishnan K., Mokri B., Parisi J.E., et al. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol. 37:1995;67.
4. Hess K.R. Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol. 42:1999;227.
5. Fadul C., Wood J., Thaler H., et al. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology. 38:1988;1374.
6. Walker M.D., Alexander E. Jr, Hunt W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas a cooperative clinical trial . J Neurosurg. 49:1978;333.
7. Suh J.H., Barnett G.H. Brachytherapy for brain tumor. Hematol Oncol Clin North Am. 13:1999;635.
8. Fine H.A., Dear K.B., Loeffler J.S., Black P.M., Canellos G.P. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 71:1993;2585.
9. Yung W.K., Prados M.D., Yaya-Tur R., et al. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol. 17:1999;2762.
10. Fine H.A., Figg W.D., Jaeckle K., et al. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol. 18:2000;708.
11. Ram Z., Culver K.W., Oshiro E.M., et al. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med. 3:1997;1354.
12. Begin M.E., Ells G., Das U.N., Horrobin D.F. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. J Natl Cancer Inst. 77:1986;1053.
13. Das U.N. Tumoricidal action of cis-unsaturated fatty acids and its relationship to free radicals and lipid peroxidation. Cancer Lett. 50:1991;235.
14. Das U.N. Gamma-linolenic acid, arachidonic acid and eicosapentaenoic acid as potential anti-cancer drugs. Nutrition. 6:1990;428.
15. Leary W.P., Robinson K.M., Booyens J., Dippenar N. Some effects of gamma-linolenic acid on cultured human esophageal carcinoma cells. S Afr Med J. 82:1984;681.
16. Begin M.E., Das U.N., Ells G., Horrobin D.F. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins Leukot Med. 19:1985;177.
17. Albino A.P., Juan G., Traganos F., et al. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid with increased pRb phosphorylation . Cancer Res. 60:2000;4139.
18. Begin M.E., Das U.N., Ells G. Cytotoxic effects of essential fatty acids (EFA) in mixed cultures of normal and malignant human cells. Prog Lipid Res. 25:1986;573.
19. Karmali R.A., March J., Fuchs C. Effects of omega-3-fatty acids on growth of a rat mammary tumor. J Natl Cancer Inst. 73:1984;475.
20. El-Ela S.H.A., Prasse K.W., Carroll R., Bunce O.R. Effects of dietary primrose oil on mammary tumorigenesis induced by 7, 12-dimethyl benz(a)anthracene. Lipids. 22:1987;1041.
21. Ramesh G., Das U.N. Effect of cis-unsaturated fatty acids on Meth-A ascitic tumor cells in vitro and in vivo. Cancer Lett. 123:1998;207.
22. Ramesh G., Das U.N., Koratkar R., Padma M., Sangeetha P.S. Effect of essential fatty acids on tumor cells. Nutrition. 8:1992;343.
23. Rose D.P., Connolly J.M. Antiangiogenicity of docosahexaenoic acid and its role in the suppression of cancer cell growth in nude mice. Int J Oncol. 15:1999;1011.
24. Naidu M.R.C., Das U.N., Kishan A. Intratumoral gamma-linolenic acid therapy of human gliomas. Prostaglandins Leukot Essent Fatty Acids. 45:1992;181.
25. Das U.N., Prasad V.V.S.K., Reddy D.R. Local application ofγ-linolenic acid in the treatment of human gliomas. Cancer Lett. 94:1995;147.
26. Kaye A.H. Adjuvant treatment of malignant brain tumors. Aust N Z J Surg. 59:1989;831.
27. Kornblith P.L., Walker M. Chemotherapy for malignant gliomas. J Neurosurg. 68:1988;1.
28. Kaye A.H., Morstyn G., Apuzzo M.L.J. Photoradiation therapy and its potential in the management of neurological tumors. J Neurosurg. 69:1988;1.
29. Barba D., Saris S.C., Holder C., Rosenberg S.A., Oldfield E.H. Intratumoral LAK cell and interleukin-2 therapy of human gliomas. J Neurosurg. 70:1989;175.
30. Prados M.D., Scott C., Curran W.J. Jr, et al. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma a retrospective review of Radiation Therapy Oncology Group protocols comparing survival with carmustine or PCV adjuvant chemotherapy . J Clin Oncol. 17:1999;3389.
31. Cai J., Jiang W.G., Mansel R.E. Inhibition of angiogenic factor- and tumor-induced angiogenesis by gamma linolenic acid. Prostaglandins Leukot Essent Fatty Acids. 60:1999;21.
32. Vartak S., Robbins M.E., Spector A.A. Polyunsaturated fatty acids increase the sensitivity of 36B10 rat astrocytoma cells to radiation-induced cell kill. Lipids. 32:1997;283.
33. Sangeetha P.S., Das U.N. Gamma-linolenic acid and eicosapentaenoic acid potentiate the cytotoxicity of anti-cancer drugs on human cervical carcinoma (HeLa) cells in vitro. Med Sci Res. 21:1993;457.
34. Madhavi N., Das U.N. Reversal of KB-3-1 and KB-Ch-8-5 tumor cell drug resistance by cis-unsaturated fatty acids in vitro. Med Sci Res. 22:1994;689.
35. Das U.N., Madhavi N., Padma M., Sagar P.S. Can tumor cell drug-resistance be reversed by essential fatty acids and their metabolites? Prostaglandins Leukotrienes Essent Fatty Acids. 58:1998;39.
36. Earnest F. IV, Kelly P.J., Scheithauer B.W., et al. Cerebral astrocytomas histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy . Radiology. 166:1988;823.
37. Daumas-Duport C., Monsaigneon V., Blond S., et al. Serial stereotactic biopsies and CT scan in gliomas correlative study in 100 astrocytomas, oligo-astrocytomas and oligodendrocytomas . J Neurooncol. 4:1987;317.
38. Bell H.S., Wharton S.B., Leaver H.A., Whittle I.R. Effects of n-6 essential fatty acids on glioma invasion and growth experimental studies with glioma spheroids in collagen gels . J Neurosurg. 91:1991;989.
39. Vartak S., McGaw R., Davis C.S., Robbins M.E., Spector A.A. Gamma-linolenic acid (GLA) is cytotoxic to 36B10 malignant astrocytoma cells but not to 'normal' rat astrocytes. Br J Cancer. 77:1998;1612.
40. Kenny F.S., Pinder S.E., Ellis I.O., et al. Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. Int J Cancer. 85:2000;643.
41. Menendez J.A., del Mar Barbacid M., Montero S., et al. Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. Eur J Cancer. 37:2001;402.